Atara Biotherapeutics, Inc. · NASDAQ:ATRA

Point72 Asset Management, L.P. reported a 7.60% stake in Atara Biotherapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Point72 Asset Management, L.P. reported a 7.60% stake in Atara Biotherapeutics, Inc., 687,718 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
7.60%
Shares
687,718
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.7.60%687,718
Point72 Capital Advisors, Inc.7.60%687,718
Steven A. Cohen7.60%687,718

Source

View original at SEC

Related